Publicacións nas que colabora con Federico Garrido Torres-Puchol (37)

2021

  1. CRC: A Darwinian model of cellular immunoselection

    Foundations of Colorectal Cancer (Elsevier), pp. 529-541

  2. Tumor escape phenotype in bladder cancer is associated with loss of HLA class I expression, T-cell exclusion and stromal changes

    International Journal of Molecular Sciences, Vol. 22, Núm. 14

2018

  1. HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15

    Immunogenetics, Vol. 70, Núm. 10, pp. 647-659

  2. HLA class I loss and PD-L1 expression in lung cancer: Impact on T-cell infiltration and immune escape

    Oncotarget, Vol. 9, Núm. 3, pp. 4120-4133

2015

  1. Colorectal cancer classification and cell heterogeneity: A systems oncology approach

    International Journal of Molecular Sciences, Vol. 16, Núm. 6, pp. 13610-13632

  2. Cáncer colorrectal: un modelo darwiniano de inmuno-selección celular

    Abordaje multidisciplinar de cáncer colorrectal (Andavira), pp. 453-470

2013

  1. Immune in filtrates are prognostic factors in localized gastrointestinal stromal tumors

    Cancer Research, Vol. 73, Núm. 12, pp. 3499-3510

2012

  1. Genome-wide differential genetic profiling characterizes colorectal cancers with genetic instability and specific routes to HLA class I loss and immune escape

    Cancer Immunology, Immunotherapy, Vol. 61, Núm. 6, pp. 803-816

  2. Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes

    Cancer Immunology, Immunotherapy, Vol. 61, Núm. 9, pp. 1359-1371

2011

  1. Leukocyte infiltrate in gastrointestinal adenocarcinomas is strongly associated with tumor microsatellite instability but not with tumor immunogenicity

    Cancer Immunology, Immunotherapy, Vol. 60, Núm. 6, pp. 869-882

2010

  1. Higher HLA class i expression in renal cell carcinoma than in autologous normal tissue

    Tissue Antigens, Vol. 75, Núm. 2, pp. 110-118

2009

  1. A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma

    Human Immunology, Vol. 70, Núm. 1, pp. 60-64

2005

  1. Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas

    Cancer Immunology, Immunotherapy, Vol. 54, Núm. 9, pp. 858-866

2004

  1. Promyelocytic leukemia (PML) nuclear bodies are disorganized in colorectal tumors with total loss of major histocompatibility complex class I expression and LMP7 downregulation

    Tissue Antigens, Vol. 63, Núm. 5, pp. 446-452

2000

  1. Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression

    Cancer Immunology Immunotherapy, Vol. 48, Núm. 12, pp. 684-690

1998

  1. Differential expression of MHC class II genes in lung tumour cell lines

    European Journal of Immunogenetics, Vol. 25, Núm. 6, pp. 385-391

  2. Microsatellite instability in cervical intraepithelial neoplasia

    Journal of Experimental and Clinical Cancer Research, Vol. 17, Núm. 3, pp. 361-366

1997

  1. Class I major histocompatibility complex antigens and tumor ploidy in breast and bronchogenic carcinomas

    Cancer Detection and Prevention, Vol. 21, Núm. 1, pp. 22-28

  2. Lack of correlation between codon 12 K-ras mutations and major histocompatibility complex antigens in bronchogenic carcinomas

    Cancer Detection and Prevention, Vol. 21, Núm. 5, pp. 412-417

1995

  1. DIFFERENT PATTERNS OF HLA‐DR ANTIGEN EXPRESSION IN NORMAL EPITHELIUM, HYPERPLASTIC AND NEOPLASTIC MALIGNANT LESIONS OF THE BREAST

    International Journal of Immunogenetics, Vol. 22, Núm. 4, pp. 299-310